Our team

Your team, including a dedicated Patient Access Manager and Nurse Navigator, will be there to answer your questions and offer you personalized support.

Enroll in Patient Support Learn more about the program

Alyssa

Patient Access Management Team Member

Patient Access Managers

When you enroll in Madrigal Patient Support®, your dedicated Patient Access Manager will reach out to you to explain how we can help. Your Patient Access Manager will help you understand your insurance coverage and explore financial assistance options. Your Patient Access Manager will also coordinate with your specialty pharmacy to deliver your medication straight to your home address.

If you have questions about the specialty pharmacy process or their communication, your Patient Access Manager is ready to help.

Your Patient Access Manager can help with:

Navigating Madrigal Patient Support programs and resources

Understanding your insurance coverage

Exploring financial assistance options

Knowing what to expect with the specialty pharmacy process

Hasan

Nurse Navigator Team Member

Nurse Navigators

Our Nurse Navigators provide support and education throughout your treatment journey. They can answer questions, check in when you prefer, and help you feel confident and informed every step of the way.

Nurse Navigators can help with:

Telephone nursing support

Education and resources to help you learn about MASH with liver scarring*
*Moderate to advanced liver scarring (fibrosis) without cirrhosis

Reminders and tools to help you stay on track with treatment

Tips to manage symptoms and know when to reach out to your doctor

Madrigal Patient Support played a crucial role when I started Rezdiffra® (resmetirom). They checked in with me regularly and provided helpful resources for accessing the medication, and they helped me with the cost. That kind of support gives peace of mind.

Mary Rezdiffra Real Voices™ Ambassador
Patient Ambassadors are sponsored by Madrigal Pharmaceuticals.

Frequently asked questions

When you join Madrigal Patient Support, you’ll be paired with a dedicated Patient Access Manager, your main point of contact. They can help with enrollment, insurance questions, and financial assistance. If you need education about your condition or medicine, your Patient Access Manager can help with enrollment, insurance questions, and exploring financial assistance options.

When you are enrolled into the program, your Patient Access Manager will reach out to you via telephone to welcome you. You can expect a call within a few days of your enrollment. If you have any questions, you can always call Madrigal Patient Support at 1-877-219-7770, Monday – Friday, 8 AM – 8 PM ET.

Yes, we have Patient Access Managers who speak Spanish, and we also offer support in multiple other languages. Please call Madrigal Patient Support at 1-877-219-7770, Monday – Friday, 8 AM – 8 PM ET, and let us know your language preference.

You’ll get a call from your specialty pharmacy or Madrigal Patient Support to schedule your delivery. Be sure to answer the call to avoid delays.

Most patients typically receive their medication within about 30 days.

Your Nurse Navigator specializes in gastroenterology and hepatology. They can provide education about your condition and treatment if you are prescribed Rezdiffra® (resmetirom).

Your healthcare provider is the best source of information about your treatment and your health.

Our Nurse Navigator team can provide education about your condition and your prescribed medication. Your Nurse Navigator can explaing how it works, what to expect, and answer questions you may have.

Please let our team know if you would prefer to connect with a Spanish-speaking Nurse Navigator.

Keep in mind: Your healthcare provider is the best source of information about your treatment and your health.

Actor portrayal on couch with tablet Actor portrayal

Our support begins when you sign up

At no cost to you.

Enroll in Patient Support Learn more about the program

Have questions? Give us a call

1-877-219-7770

Monday – Friday, 8 AM – 8 PM ET

Spanish-speaking representatives available

Back to top

Indication and Important Safety Information

What is Rezdiffra?

Rezdiffra is a prescribed medicine used along with diet and exercise to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver.

This indication is approved based on improvement of MASH and liver scarring (fibrosis). There are ongoing studies to confirm the clinical benefit of Rezdiffra.

Before you take Rezdiffra, tell your healthcare provider about all of your medical conditions, including if you:

  • have any liver problems other than MASH.
  • have gallbladder problems or have been told you have gallbladder problems, including gallstones
  • are pregnant or plan to become pregnant. It is not known if Rezdiffra will harm your unborn baby.
    • A pregnancy safety study for women who take Rezdiffra during pregnancy collects information about the
      health of you and your baby. You or your healthcare provider can report your pregnancy by visiting https://pregnancyregistry.madrigalpharma.com/ or calling 1-800-905-0324.
  • are breastfeeding or plan to breastfeed. It is not known if Rezdiffra passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take Rezdiffra.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

  • Rezdiffra and other medicines may affect each other, causing side effects. Rezdiffra may affect the way other medicines work, and other medicines may affect how Rezdiffra works.
  • Especially tell your healthcare provider if you take medicines that contain gemfibrozil to help lower your triglycerides because Rezdiffra is not recommended in patients taking these medicines.
  • Tell your healthcare provider if you are taking medicines such as clopidogrel to thin your blood or statin medicines to help lower your cholesterol.
  • Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

What are the possible side effects of Rezdiffra?

Rezdiffra may cause serious side effects, including:

  • liver injury (hepatotoxicity). Stop taking Rezdiffra and call your healthcare provider right away if you develop the following signs or symptoms of hepatotoxicity: tiredness, nausea, vomiting, fever, rash, your skin or the white part of your eyes turns yellow (jaundice), or stomach pain/tenderness.
  • gallbladder problems. Gallbladder problems such as gallstones, or inflammation of the gallbladder, or inflammation of the pancreas from gallstones can occur with MASH and may occur if you take Rezdiffra. Call your healthcare provider right away if you develop any signs or symptoms of these conditions, including nausea, vomiting, fever, or pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen to your back and the pain may happen with or without vomiting.

The most common side effects of Rezdiffra include diarrhea, nausea, itching, stomach pain, vomiting, dizziness, and constipation.

These are not all the possible side effects of Rezdiffra. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Madrigal Pharmaceuticals, Inc. at 1-800-905-0324.

Please see the full Prescribing Information, including Patient Information, for Rezdiffra.

Indication and Important Safety Information

What is Rezdiffra?

Rezdiffra is a prescribed medicine used along with diet and exercise to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver.

This indication is approved based on improvement of MASH and liver scarring (fibrosis). There are ongoing studies to confirm the clinical benefit of Rezdiffra.

Before you take Rezdiffra, tell your healthcare provider about all of your medical conditions, including if you:

  • have any liver problems other than MASH.
  • have gallbladder problems or have been told you have gallbladder problems, including gallstones
  • are pregnant or plan to become pregnant. It is not known if Rezdiffra will harm your unborn baby.
    • A pregnancy safety study for women who take Rezdiffra during pregnancy collects information about the
      health of you and your baby. You or your healthcare provider can report your pregnancy by visiting https://pregnancyregistry.madrigalpharma.com/ or calling 1-800-905-0324.
  • are breastfeeding or plan to breastfeed. It is not known if Rezdiffra passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take Rezdiffra.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

  • Rezdiffra and other medicines may affect each other, causing side effects. Rezdiffra may affect the way other medicines work, and other medicines may affect how Rezdiffra works.
  • Especially tell your healthcare provider if you take medicines that contain gemfibrozil to help lower your triglycerides because Rezdiffra is not recommended in patients taking these medicines.
  • Tell your healthcare provider if you are taking medicines such as clopidogrel to thin your blood or statin medicines to help lower your cholesterol.
  • Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

What are the possible side effects of Rezdiffra?

Rezdiffra may cause serious side effects, including:

  • liver injury (hepatotoxicity). Stop taking Rezdiffra and call your healthcare provider right away if you develop the following signs or symptoms of hepatotoxicity: tiredness, nausea, vomiting, fever, rash, your skin or the white part of your eyes turns yellow (jaundice), or stomach pain/tenderness.
  • gallbladder problems. Gallbladder problems such as gallstones, or inflammation of the gallbladder, or inflammation of the pancreas from gallstones can occur with MASH and may occur if you take Rezdiffra. Call your healthcare provider right away if you develop any signs or symptoms of these conditions, including nausea, vomiting, fever, or pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen to your back and the pain may happen with or without vomiting.

The most common side effects of Rezdiffra include diarrhea, nausea, itching, stomach pain, vomiting, dizziness, and constipation.

These are not all the possible side effects of Rezdiffra. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Madrigal Pharmaceuticals, Inc. at 1-800-905-0324.

Please see the full Prescribing Information, including Patient Information, for Rezdiffra.